MECOM and chronic obstructive pulmonary disease: The GWAS data confirmed that the variants in the 6 COPD-hub genes (IRAK2, MECOM, CDC42BPA, ASB4, DPF3 and TMEM67) shows genome wide significant association to traits that could potentially modify the risk of COPD pathology development.